Halozyme Therapeutics Correlations

HALO Stock

USD 64.85 0.83 1.30%

The current 90-days correlation between Halozyme Therapeutics and Insmed Inc is 0.22 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Halozyme Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Halozyme Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Halozyme Therapeutics Correlation With Market

Modest diversification

The correlation between Halozyme Therapeutics and DJI is 0.26 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Halozyme Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Halozyme Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

To learn how to invest in Halozyme Stock, please use our How to Invest in Halozyme Therapeutics guide.

Moving together with Halozyme Stock

0.75	PLX	Protalix Biotherapeutics	Pair Corr
0.8	LUCD	Lucid Diagnostics	Pair Corr
0.84	WM	Waste Management	Pair Corr
0.84	GE	GE Aerospace	Pair Corr
0.61	CSCO	Cisco Systems	Pair Corr
0.84	JNJ	Johnson Johnson	Pair Corr
0.88	MMM	3M Company	Pair Corr
0.82	T	ATT Inc Aggressive Push	Pair Corr
0.76	XOM	Exxon Mobil Corp Earnings Call This Week	Pair Corr
0.71	IBM	International Business	Pair Corr
0.87	CVX	Chevron Corp	Pair Corr

Moving against Halozyme Stock

0.9	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.89	CDIO	Cardio Diagnostics	Pair Corr
0.85	CDIOW	Cardio Diagnostics	Pair Corr
0.85	ASMB	Assembly Biosciences Earnings Call Tomorrow	Pair Corr
0.76	SCLX	Scilex Holding	Pair Corr
0.7	ELVN	Enliven Therapeutics Downward Rally	Pair Corr
0.53	OCEAW	Ocean Biomedical	Pair Corr
0.51	CMND	Clearmind Medicine Common	Pair Corr
0.78	MSFT	Microsoft Aggressive Push	Pair Corr
0.64	DIS	Walt Disney	Pair Corr
0.53	MRK	Merck Company	Pair Corr
0.46	CAT	Caterpillar	Pair Corr
0.4	HD	Home Depot	Pair Corr

Related Correlations Analysis

	AGIO	INSM	CERE	RARE	BMRN	SGEN	ALNY	EXEL	ALEC	LEGN
AGIO		-0.13	0.0	0.6	-0.19	0.0	-0.07	-0.19	0.55	-0.19	AGIO
INSM	-0.13		0.0	0.08	0.04	0.0	0.61	0.11	-0.34	0.74	INSM
CERE	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	CERE
RARE	0.6	0.08	0.0		-0.59	0.0	0.29	-0.7	0.74	-0.04	RARE
BMRN	-0.19	0.04	0.0	-0.59		0.0	-0.41	0.73	-0.52	0.16	BMRN
SGEN	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	SGEN
ALNY	-0.07	0.61	0.0	0.29	-0.41	0.0		-0.34	-0.15	0.4	ALNY
EXEL	-0.19	0.11	0.0	-0.7	0.73	0.0	-0.34		-0.58	-0.01	EXEL
ALEC	0.55	-0.34	0.0	0.74	-0.52	0.0	-0.15	-0.58		-0.25	ALEC
LEGN	-0.19	0.74	0.0	-0.04	0.16	0.0	0.4	-0.01	-0.25		LEGN
	AGIO	INSM	CERE	RARE	BMRN	SGEN	ALNY	EXEL	ALEC	LEGN

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

LEGN	+ 0.74	INSM
ALEC	+ 0.74	RARE
EXEL	+ 0.73	BMRN
ALNY	+ 0.61	INSM
RARE	+ 0.6	AGIO
ALEC	+ 0.55	AGIO

High negative correlations

EXEL	- 0.7	RARE
BMRN	- 0.59	RARE
ALEC	- 0.58	EXEL
ALEC	- 0.52	BMRN
ALNY	- 0.41	BMRN
EXEL	- 0.34	ALNY

Risk-Adjusted Indicators

There is a big difference between Halozyme Stock performing well and Halozyme Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Halozyme Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
AGIO	2.13	(0.37)	0.00	(0.53)	0.00	0.00	3.88	(4.71)	11.52
INSM	1.63	0.16	0.08	0.16	2.14	(1.77)	3.63	(3.26)	12.30
CERE	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
RARE	1.93	(0.16)	0.00	(0.21)	0.00	0.00	4.02	(3.87)	11.45
BMRN	1.17	0.15	0.10	1.94	1.61	(1.11)	3.04	(3.32)	8.07
SGEN	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ALNY	1.97	0.34	0.16	0.26	1.86	(2.45)	4.69	(3.48)	15.40
EXEL	1.62	0.10	0.04	0.18	2.55	(1.54)	4.41	(3.83)	14.29
ALEC	3.41	(0.42)	0.00	(0.31)	0.00	0.00	7.60	(5.82)	23.91
LEGN	2.33	0.17	0.08	(0.71)	2.49	(2.59)	6.15	(4.40)	14.84

Halozyme Therapeutics Corporate Management

Mark Esq	Senior Officer	Profile
Kristin Schwartzbauer	Head Quality	Profile
Gary Grote	Chief Officer	Profile
Nicole LaBrosse	CFO Director	Profile
MD MBA	Chief Officer	Profile
Amy Fox	Senior Resources	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC